Navigation Links
The Leukemia & Lymphoma Society's (LLS) Greater Bay Area Chapter to Host the 2014 Emerging Therapies & Survivorship Conference
Date:12/10/2013

SAN FRANCISCO, Dec. 10, 2013 /PRNewswire-USNewswire/ -- The Leukemia & Lymphoma Society's (LLS) Greater Bay Area Chapter will be hosting its annual Emerging Therapies & Survivorship Conference for blood cancer patients on Saturday, January 25, 2014, from 8:30 a.m. to 12:30 p.m. PT at the Hyatt Regency San Francisco.  The Emerging Therapies & Survivorship Conference is a free event that brings the latest advances in blood cancer research and clinical trials to Northern California blood cancer patients, caregivers and healthcare professionals.  LLS is honored to be hosting keynote speaker Dan Shapiro, Ph.D., psychologist, professor, author and professional speaker, to give his notable talk, A Funny Thing Happened on My Way to Chemotherapy.

The Emerging Therapies & Survivorship Conference will begin with breakfast and a welcome message from LLS, and continue with the keynote speech, exhibitor sessions and concurrent breakout sessions.  During the breakout sessions, attendees will have the opportunity to speak with hematology experts about various blood cancers, including acute myeloid leukemia, myelodysplastic syndromes, non-Hodgkin lymphoma, and more.  To view the complete conference program agenda, please click here.

Sponsors for the 2014 Emerging Therapies & Survivorship Conference include Millennium, Genentech, Onyx Pharmaceuticals, Celgene, and Gilead and partners include Association of Northern California Oncologists, Marin Specialty Care, Redwood Regional Medical Group, Stanford Cancer Center, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, and Sutter Medical Center of Santa Rosa.

The Emerging Therapies & Survivorship Conference is a free educational event and will be taking place on Saturday, January 25, 2014, from 8:30 a.m. to 12:30 p.m. PT at the Hyatt Regency San Francisco, located at 5 Embarcadero Center, San Francisco, Calif., 94111.  Space is limited and registration is required.  To reserve your space, register online at bit.ly/emergingtherapies

For more information about the conference, contact Lauren Wilkerson, MPH, MSW, at 415-625-1115 or visit www.lls.org/gba.

About The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society ® (LLS) is the world's largest voluntary health agency dedicated to blood cancer.  The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families.  LLS funds lifesaving blood cancer research around the world and provides free information and support services for patients and their loved ones.

Major LLS fundraising campaigns include Team In Training, Light The Night Walk, School & Youth, Man & Woman of the Year and Leukemia Cup Regatta.  To reach the widest possible audience, LLS partners with national and regional level companies and brands, including Nike, Disney, Burlington and others.

Founded in 1949 and headquartered in White Plains, NY, LLS has chapters throughout the United States and Canada.  To learn more, visit www.LLS.org.  Patients and caregivers should contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET.Greater Bay Area Chapter OfficesSan Francisco

221 Main Street, Suite 1650, San Francisco, CA 94105, 415-625-1100Silicon Valley/Monterey

675 North First Street, Suite 1100, San Jose, CA 95112, 408-490-2666North Bay

2455 Bennett Valley Road, Suite B204, Santa Rosa, CA 95404 707-544-4350


'/>"/>
SOURCE Leukemia & Lymphoma Society - Greater Bay Area Chapter
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BioLineRx Presents Positive Preclinical Results of Acute Myeloid Leukemia Treatment at ASH Conference
2. Cell Therapeutics Announces Presentation of Interim Results from Phase 2 Tosedostat Trial in Older Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) at ASH Annual Meeting
3. Ibrutinib Data Published in The Lancet Oncology Suggest a Positive Effect in Previously Untreated Chronic Lymphocytic Leukemia Patients Over Age 65
4. New Study Finds Targeted Treatment Can Significantly Reduce Relapse Risk In High-Risk Children With Acute Myeloid Leukemia
5. Improved Efficacy, Limited Toxicity of Targeted Therapies Brighten the Future of Treatment for Chronic Lymphocytic Leukemia
6. Novartis highlights research on investigational, personalized T cell therapy CTL019 in patients with forms of acute and chronic leukemia
7. Polaris Group Files New IND for ADI-PEG 20 in Leukemia
8. The Leukemia & Lymphoma Society Applauds FDAs Approval of Ibrutinib for Certain Patients with Mantle Cell Lymphoma
9. Polaris Group Announces Treatment of First Patient in Phase 2 Study of ADI-PEG 20 in Acute Myeloid Leukemia
10. Top Trial Firm Cohen, Placitella & Roth, PC Investigating Ariad Pharmaceuticals, Inc., for Suspending Sales of its Leukemia Drug Iclusig
11. The Leukemia & Lymphoma Society Issues Statement Regarding the Status of Iclusig (Ponatinib)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... May 24, 2016  Diana Russell suffers from a ... from the inside out.  This disease has put her ... her children and grandchildren to leave her home.  Because ... family cannot haul the wheelchair.  So if there is ... and Diana is left to wait for the bus. ...
(Date:5/24/2016)... Celsion Corporation (NASDAQ: CLSN ... an update on its ongoing OVATION study, a ... the Company,s DNA-based immunotherapy, with the standard of ... advanced ovarian cancer who will undergo neoadjuvant chemotherapy ... IL-12 DNA plasmid vector formulated as a nanoparticle ...
(Date:5/24/2016)... , May 24, 2016 ... de doble terapia del mundo, introduce catéteres para ... OrbusNeich, una compañía global especializada en ... vidas, ha expandido su cartera incluyendo productos para ... JADE™ y Scoreflex™ PTA son los dispositivos de ...
Breaking Medicine Technology:
(Date:5/24/2016)... ... May 24, 2016 , ... ... is pleased to welcome new Partner Firm Austin & Co., Inc. Headquartered ... to insurance, employee benefits, HR consulting, benefits technology, and beyond. As an ...
(Date:5/24/2016)... (PRWEB) , ... May 24, 2016 , ... How to ... · Raleigh, NC, http://www.fdanews.com/humanerrordrugdevice , Human error is known to be the ... that human error will ever be totally eliminated, many human performance problems can be ...
(Date:5/24/2016)... — , ... (PRWEB) ... of three new members of its Advisory Board. Joining the ... Sarah Kusch. “All three of them embody the mission of our ... are very fortunate to have them as we continue to expand ...
(Date:5/24/2016)... ... May 24, 2016 , ... Backed by ... logger for each job, ensuring the best suited solution to meet regulatory requirements. ... loggers at their lab in Istanbul. , Metroloji Okulu specializes in MadgeTech’s line ...
(Date:5/24/2016)... ... May 24, 2016 , ... The Radiosurgery Society ... of radiosurgery, is recognizing five medical residents and students for their outstanding contributions ... (SBRT). The awards will be presented at the 2016 SRS/SBRT Scientific Meeting taking ...
Breaking Medicine News(10 mins):